The influence of NAD+-linked substrates on energy conservation at sites 2 and 3 in mitochondria treated with inorganic arsenate.
D000090:Acetoacetates / Q000378:metabolism; D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D001149:Arsenates / Q000494:pharmacology*; D001151:Arsenic / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects*; D005971:Glutamates / Q000378:metabolism; D006885:Hydroxybutyrates / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000378:metabolism; D009243:NAD / Q000378:metabolism*; D051381:Rats; D013386:Succinates / Q000378:metabolism
D000090:Acetoacetates; D000227:Adenine Nucleotides; D001149:Arsenates; D005971:Glutamates; D006885:Hydroxybutyrates; D013386:Succinates; D009243:NAD; D001151:Arsenic; D001205:Ascorbic Acid